We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $64.8B
1-Year Est. Return 42.7%
This Fund
S&P 500
This Quarter Est. Return
+1.09%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$50.8B
AUM Growth
-$294M
Cap. Flow
-$328M
Cap. Flow %
-0.65%
Top 10 Hldgs %
22.21%
Holding
1,137
New
127
Increased
273
Reduced
442
Closed
122

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$255M
2
TXT icon
Textron
TXT
+$206M
3
AZN icon
AstraZeneca
AZN
+$164M
4
XOM icon
ExxonMobil
XOM
+$124M
5
MRNA icon
Moderna
MRNA
+$121M

Sector Composition

Rank Sector Weight
1 Technology 22.3%
2 Healthcare 15.98%
3 Financials 14.49%
4 Consumer Discretionary 11.52%
5 Communication Services 8.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRPL icon
676
Purple Innovation
PRPL
$39.3M
$10.5M 0.02%
+20,000
New +$12.5M
FIVN icon
677
FIVE9
FIVN
$2.17B
$10.4M 0.02%
65,000
+60,000
+1,200% +$10.9M
GENI icon
678
Genius Sports
GENI
$2.09B
$10.3M 0.02%
550,000
-300,000
-35% -$5.49M
NCLH icon
679
Norwegian Cruise Line
NCLH
$8.89B
$10.1M 0.02%
377,100
-5,700
-1% -$145K
MLTX icon
680
MoonLake Immunotherapeutics
MLTX
$1.53B
$10.1M 0.02%
1,011,589
ARYD
681
DELISTED
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
$10.1M 0.02%
1,000,000
OMEG
682
DELISTED
Omega Alpha SPAC Class A Ordinary Shares
OMEG
$10M 0.02%
1,030,770
ULTA icon
683
Ulta Beauty
ULTA
$23.2B
$10M 0.02%
27,800
-800
-3% -$289K
INBX
684
DELISTED
Inhibrx, Inc. Common Stock
INBX
$9.99M 0.02%
+300,000
New +$9.13M
PRDS
685
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
$9.95M 0.02%
1,000,000
AUS
686
DELISTED
Austerlitz Acquisition Corporation I
AUS
$9.94M 0.02%
1,000,000
AEE icon
687
Ameren
AEE
$30B
$9.92M 0.02%
+122,490
New +$10.4M
DLO icon
688
dLocal
DLO
$4.35B
$9.87M 0.02%
180,971
+3,384
+2% +$189K
NWSA icon
689
News Corp Class A
NWSA
$16.1B
$9.81M 0.02%
416,910
-6,000
-1% -$142K
FVT
690
DELISTED
Fortress Value Acquisition Corp. III
FVT
$9.76M 0.02%
1,000,000
HCII
691
DELISTED
Hudson Executive Investment Corp. II Class A Common Stock
HCII
$9.75M 0.02%
1,000,000
ASZ
692
DELISTED
Austerlitz Acquisition Corporation II
ASZ
$9.75M 0.02%
1,000,000
PLNT icon
693
Planet Fitness
PLNT
$4.05B
$9.74M 0.02%
+123,972
New +$9.42M
JNPR
694
DELISTED
Juniper Networks
JNPR
$9.74M 0.02%
353,800
-5,000
-1% -$141K
CPAR
695
DELISTED
Catalyst Partners Acquisition Corp. Class A Ordinary Share
CPAR
$9.73M 0.02%
+1,000,000
New +$9.71M
AKIC
696
DELISTED
Sports Ventures Acquisition Corp. Class A Ordinary Shares
AKIC
$9.73M 0.02%
1,000,000
LOKM
697
DELISTED
Live Oak Mobility Acquisition Corp.
LOKM
$9.67M 0.02%
1,000,000
EQH icon
698
Equitable Holdings
EQH
$14.2B
$9.63M 0.02%
325,000
+25,000
+8% +$757K
SE icon
699
Sea Limited
SE
$68B
$9.56M 0.02%
+30,000
New +$9.21M
FSBC icon
700
Five Star Bancorp
FSBC
$1.12B
$9.54M 0.02%
398,348
+124,152
+45% +$2.98M

Similar funds

Adage Capital Partners's Q3 2021 Portfolio in Review

As of Q3 2021, Adage Capital Partners held 1,137 positions worth $50.8B, down 0.58% from $51.1B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Adage Capital Partners's Q3 2021 filing shows 127 new, 273 increased, 442 reduced and 122 closed positions. Its largest new stake was Pfizer: 5,759,101 shares worth $248M. The largest sale was Alexion Pharmaceuticals, an estimated $962M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

  • Adage Capital Partners's largest Q3 2021 buy was Pfizer: 5,759,101 shares worth $248M.
  • Adage Capital Partners added most to Textron in Q3 2021, an estimated $206M increase.
  • Adage Capital Partners's biggest Q3 2021 reduction was Devon Energy, cutting an estimated $201M.
  • Adage Capital Partners fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $962M.
  • Adage Capital Partners's ten largest holdings make up 22% of its $50.8B portfolio in Q3 2021.
  • Adage Capital Partners opened 127 new positions and closed 122 in Q3 2021.
  • Adage Capital Partners's portfolio value fell 0.58% quarter-over-quarter to $50.8B.

Based on Adage Capital Partners's 13F filing for Q3 2021, filed 15 Nov 2021.